ASG vs TSBK

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and an absent Altman Z-Score, preventing a full distress risk assessment. Despite a low P/E of 9.54 compared to the sector average of 21.57 and a Price/Book of 0.90 suggesting possible value appeal, the company faces severe operational challenges, including negative operating margin (-125.62%) and steep year-over-year declines in revenue (-13.20%) and earnings (-80.60%). The high dividend yield of 8.94% appears unsustainable given the 82.14% payout ratio amid falling earnings, while technical indicators signal a bearish trend. Although the stock trades above the Graham Number of $8.64, current price of $5.34 appears misleadingly low due to deteriorating fundamentals and lack of analyst coverage.

TSBK presents a dichotomy between strong fundamental value and bearish sentiment. The company maintains a stable health profile with a Piotroski F-Score of 4/9 and trades at a significant discount to both its Graham Number ($54.32) and Intrinsic Value ($113.58). While earnings growth is robust at 20.9% YoY and the P/E ratio is attractive at 10.72, these positives are heavily offset by a very bearish technical trend (10/100) and aggressive insider selling by the CFO and President. The stock is fundamentally undervalued but currently lacks a positive catalyst.